Brief: MYnd Analytics Awarded European Patent On Neuromodulation Platform
28/03/2019 13:24
March 28 (Reuters) - MYnd Analytics Inc MYND.O :
* MYND ANALYTICS AWARDED EUROPEAN PATENT ON NEUROMODULATION
PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR
TREATING DEPRESSION
Source text for Eikon: ID:nGNX3bZHMG
Further company coverage: MYND.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns